Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | RAB9A | P51151 | 3/20 | 0.34 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.32 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.32 |
| ▸ | BACE1 | P56817 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14635117 | 0.82 | ALDH1A1 (0.39) | ALDH1A1RAB9ANPC1LMNAKDM4E | |
| SCHEMBL1803708 | 0.81 | ALDH1A1 (0.36) | ALDH1A1RAB9ANPC1L3MBTL1LMNA | |
| SCHEMBL698135 | 0.80 | ALDH1A1 (0.47) | ALDH1A1RAB9ANPC1L3MBTL1LMNA | |
| SCHEMBL714544 | 0.79 | ALDH1A1 (0.40) | ALDH1A1RAB9ANPC1ESR2BACE1 | |
| SCHEMBL195576 | 0.77 | LMNA (0.36) | ALDH1A1RAB9ANPC1L3MBTL1LMNA | |
| SCHEMBL723026 | 0.75 | ALDH1A1 (0.40) | ALDH1A1RAB9ANPC1L3MBTL1LMNA | |
| SCHEMBL1068489 | 0.71 | CYP1A2 (0.39) | ALDH1A1RAB9ANPC1L3MBTL1LMNA | |
| SCHEMBL1066310 | 0.71 | ALDH1A1 (0.38) | ALDH1A1RAB9ANPC1L3MBTL1KDM4E | |
| SCHEMBL721411 | 0.71 | TP53 (0.36) | ALDH1A1RAB9ANPC1L3MBTL1MAPT | |
| SCHEMBL379055 | 0.71 | ALDH1A1 (0.47) | ALDH1A1RAB9ANPC1LMNABACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2226326-B1 | METHOD FOR PRODUCING ORGANIC ALKALI METAL COMPOUND AND METHOD FOR PRODUCING ORGANIC TRANSITION METAL COMPOUND | MITSUI CHEMICALS INC (JP) | 2016-02-17 | — | — | EP | disclosed |
| US-8409480-B2 | Process for preparing organic alkali metal compound and organic transition metal compound | MITSUI CHEMICALS, INC. (JP) | 2013-04-02 | — | — | US | disclosed |
| US-20120049391-A1 | PROCESS FOR PREPARING ORGANIC ALKALI METAL COMPOUND AND ORGANIC TRANSITION METAL COMPOUND | MITSUI CHEMICALS, INC. | 2012-03-01 | — | — | US | disclosed |
| EP-2226326-A1 | METHOD FOR PRODUCING ORGANIC ALKALI METAL COMPOUND AND METHOD FOR PRODUCING ORGANIC TRANSITION METAL COMPOUND | Mitsui Chemicals, Inc. (JP) | 2010-09-08 | — | — | EP | disclosed |
| US-6849753-B2 | Process for preparation of half-vanadocene compound | NICHIA CORPORATION (JP) | 2005-02-01 | — | — | US | disclosed |
| EP-1312610-B1 | Process for preparation of half-vanadocene compound | NICHIA CORP (JP) | 2004-09-08 | — | — | EP | disclosed |
| US-20030109733-A1 | Process for preparation of half-vanadocene compound | UBE INDUSTRIES, LTD. (JP) | 2003-06-12 | — | — | US | disclosed |
| CN-1420118-A | Method for preparing semi-cyclopentadienyl vanadium | NICHIA KAGAKU KOGYO KK (JP) | 2003-05-28 | — | — | CN | disclosed |
| EP-1312610-A1 | Process for preparation of half-vanadocene compound | Nichia Corporation (JP) | 2003-05-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120049391-A1 | PROCESS FOR PREPARING ORGANIC ALKALI METAL COMPOUND AND ORGANIC TRANSITION METAL COMPOUND | NHP2, SSRP1, RER1 | ALDH1A1 2243/4885RAB9A 302/4885NPC1 2382/4885 |
| US-20030109733-A1 | Process for preparation of half-vanadocene compound | CPNE4, VDAC2, VDAC1 | ALDH1A1 1870/4885RAB9A 2150/4885NPC1 434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.